Wednesday’s earnings releases showed strong growth at Vertiv and GE Vernova, higher revenue across several healthcare businesses and mixed profitability among packaging and industrial companies. This roundup covers results announced on October 28, with each company’s reported figures compared against the corresponding year-earlier quarter.
In Simple Words
Revenue shows how much a company sold, while earnings per share show the profit or loss attributable to each share. Adjusted earnings exclude specified items, so they should be read alongside GAAP figures, and guidance represents management’s expectations for future performance.
All financial figures are in USD. Tables compare Q3 2026 with Q3 2025; EPS changes are expressed in dollars per share.
1. GE Vernova: Revenue and Earnings Rise Sharply
Higher revenue and stronger profitability accompanied an increase in the full-year financial outlook.
Also Read: Top US Market News Today, October 28, 2026: Trade, Takeovers and AI Funding
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $12.642 billion | $9.969 billion | +26.8% |
| GAAP diluted EPS | $4.81 | $1.64 | +$3.17 |
| Net income attributable to GE Vernova | $1.291 billion | $452 million | +185.6% |
2026 outlook: Revenue of $46.5–$47.5 billion and free cash flow of $16–$17 billion.
2. Vertiv: Sales Growth Drives Substantial EPS Expansion
Revenue increased approximately 61%, while both GAAP and adjusted diluted EPS advanced strongly.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $4.313 billion | $2.676 billion | +61% |
| GAAP diluted EPS | $1.95 | $1.02 | +$0.93 |
| GAAP net income | $764.5 million | $398.5 million | +91.8% |
2026 outlook: Revenue of $14.45–$14.85 billion and adjusted diluted EPS of $7.10–$7.20. Fourth-quarter adjusted diluted EPS guidance is $2.22–$2.28.
3. GE HealthCare: Revenue Growth and Margin Expansion Lift Profit
Sales increased across the business, with net income growing faster than revenue.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $5.513 billion | $5.143 billion | +7.2% |
| GAAP diluted EPS | $1.36 | $0.98 | +$0.38 |
| Net income attributable to GE HealthCare | $615 million | $446 million | +37.9% |
2026 outlook: Adjusted EPS of $4.95–$5.05, approximately 4% organic revenue growth and free cash flow exceeding $1.6 billion.
4. Biogen: Revenue Grows as Earnings Decline
Higher sales were accompanied by lower adjusted earnings and a GAAP loss.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $2.804 billion | $2.535 billion | +10.6% |
| GAAP diluted EPS | −$0.14 | $3.17 | −$3.31 |
| Adjusted diluted EPS | $2.62 | $4.81 | −$2.19 |
2026 outlook: Adjusted diluted EPS of $12.20–$13.00, with the lower end increased from $12.00. Full-year revenue is expected to increase by a mid-single-digit percentage.
5. Labcorp: Sales and Adjusted Earnings Improve
Revenue growth supported higher earnings, with adjusted EPS expanding faster than GAAP EPS.
Also Read: Top Earnings Today India, October 28, 2026: Adani Enterprises, JSW Energy, Meesho and More
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $3.81 billion | $3.56 billion | +6.9% |
| GAAP diluted EPS | $3.22 | $3.12 | +$0.10 |
| Adjusted EPS | $4.78 | $4.18 | +$0.60 |
2026 outlook: Revenue growth of 5.9%–6.7% and adjusted EPS of $18.30–$18.70.
6. Boston Scientific: Modest Sales Growth Accompanies Lower GAAP Profit
Revenue increased, but GAAP net income and diluted EPS declined from the year-earlier quarter.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $5.138 billion | $5.065 billion | +1.5% |
| GAAP diluted EPS | $0.40 | $0.51 | −$0.11 |
| Net income attributable to common shareholders | $582 million | $755 million | −22.9% |
2026 outlook: Approximately 4.25% reported revenue growth and adjusted EPS of $3.16–$3.18. Fourth-quarter adjusted EPS guidance is $0.77–$0.79.
7. Aon: Organic Growth Supports Higher Adjusted EPS
Revenue rose approximately 3%, while adjusted EPS increased approximately 10%.
Also Read: US Stocks to Watch Today, October 28, 2026: Microsoft, Alphabet, Vertiv and GE Vernova in Focus
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $4.101 billion | $3.997 billion | +3% |
| GAAP diluted EPS | $2.23 | $2.11 | +$0.12 |
| Adjusted diluted EPS | $3.36 | $3.05 | +$0.31 |
Organic revenue increased 6%, and adjusted operating margin improved to 27.0% from 26.3%.
8. Generac: Record Sales Support Higher Earnings
Revenue and profit increased, supported by growth in commercial, industrial and residential products.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | Approximately $1.29 billion | Approximately $1.11 billion | +16% |
| GAAP diluted EPS | $1.83 | $1.12 | +$0.71 |
| Adjusted diluted EPS | $2.54 | $1.83 | +$0.71 |
2026 outlook: Net sales growth in the mid-to-high teens and adjusted EBITDA margin of 20.5%–21.0%.
9. Parsons: Adjusted EPS Improves Despite Lower GAAP Earnings
Revenue increased modestly, while GAAP earnings declined and adjusted profitability improved.
Also Read: S&P 500 Today, October 27, 2026: Technology Leads Gains Ahead of Fed Decision
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $1.651 billion | $1.622 billion | Approximately +2% |
| GAAP diluted EPS | $0.51 | $0.59 | −$0.08 |
| Adjusted diluted EPS | $0.89 | $0.86 | +$0.03 |
2026 outlook: Revenue of $6.25–$6.45 billion, adjusted EBITDA including noncontrolling interests of $510–$550 million and operating cash flow of $430–$490 million.
10. International Paper: Continuing-Operations Loss Widens
Nearly unchanged sales accompanied a larger continuing-operations loss, including a substantial goodwill impairment.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $6.197 billion | $6.222 billion | −0.4% |
| Loss from continuing operations | $1.097 billion | $426 million | Loss widened by $671 million |
| Adjusted EBITDA from continuing operations | $843 million | $859 million | −1.9% |
Fourth-quarter outlook: North American packaging segment operating profit of $460–$500 million and adjusted EBITDA of $700–$740 million.
11. Smurfit Westrock: Higher Sales but Lower Profitability
Revenue increased slightly, while net income and adjusted earnings declined.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $8.161 billion | $8.003 billion | +2.0% |
| GAAP basic EPS | $0.42 | $0.47 | −$0.05 |
| Net income | $219 million | $245 million | −10.6% |
Dividend: A quarterly distribution of $0.4523 per ordinary share was announced.
12. Constellium: Revenue and Net Income Advance
Higher revenue per tonne supported sales growth, while net income increased approximately 35%.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $2.639 billion | $2.166 billion | +22% |
| Net income | $119 million | $88 million | +35% |
| Adjusted EBITDA | $276 million | $235 million | +17% |
2026 outlook: Adjusted EBITDA of $1.03–$1.06 billion, excluding the non-cash metal-price-lag impact, and free cash flow exceeding $300 million.
13. Avantor: Revenue Returns to Growth and GAAP Profit Recovers
Sales increased and GAAP earnings returned to profit, while adjusted EPS remained unchanged.
Also Read: Top 10 US Earnings Today, October 27, 2026: SoFi, Coca-Cola, Boeing and More
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $1.698 billion | $1.624 billion | +4.6% |
| GAAP diluted EPS | $0.30 | −$1.04 | +$1.34 |
| Adjusted diluted EPS | $0.22 | $0.22 | Unchanged |
2026 outlook: Organic revenue growth of 0.75%–1.25%, adjusted EPS of $0.81–$0.83 and free cash flow of $525–$550 million, excluding cash restructuring costs.
14. Dana: Adjusted Earnings Turn Positive
Higher sales and stronger operating performance accompanied a recovery in adjusted EPS.
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $2.038 billion | $1.917 billion | +6.3% |
| GAAP diluted EPS, continuing operations | −$0.13 | $0.07 | −$0.20 |
| Adjusted diluted EPS | $0.41 | −$0.04 | +$0.45 |
2026 outlook: Revenue of $7.75–$7.85 billion, adjusted diluted EPS of $1.75–$2.25 and adjusted free cash flow of $275–$375 million.
15. Blackbaud: Recurring Revenue Supports EPS Growth
Revenue increased 4.1%, with adjusted diluted EPS advancing more strongly than GAAP EPS.
Also Read: Top 10 Earnings Today in India, October 27, 2026: L&T, Maruti Suzuki, Bajaj Auto and More
| Metric | Q3 2026 | Q3 2025 | YoY change |
|---|---|---|---|
| Revenue | $292.6 million | $281.1 million | +4.1% |
| GAAP diluted EPS | $1.02 | $0.98 | +$0.04 |
| Adjusted diluted EPS | $1.36 | $1.10 | +$0.26 |
2026 outlook: Revenue of $1.173–$1.179 billion and adjusted diluted EPS of $5.15–$5.25, with management expecting performance in the upper half of its guidance ranges.
Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. OneTrader is not a SEBI-registered investment adviser. Financial markets involve risk.
Keep learning with OneTrader
Explore structured lessons and practical guides to build your market knowledge.
